Skip to main content
2025 IDWeek Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
Live Streamed
On Demand
On Demand

A6. New drug development (formerly L3)

Poster Session: New Drug Development

(P-1172) Characterization of Clinical Pathogens and Microbiological Outcomes for Patients Treated with IV Fosfomycin (IV-FOS) in the ZEUS Phase 2/3 Complicated Urinary Tract Infection, including Acute Pyelonephritis (cUTI/AP) Trial

Tuesday, October 21, 2025
12:15 PM - 1:30 PM US ET
Location: Poster Hall B4-B5